Drug details
Rytary (carbidopa and levodopa capsules)
type of Decarboxylase Inhibitors
Rytary (carbidopa and levodopa) is a combination an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid, used for the treatment of Parkinson's disease, post-encephalitic Parkinsonism, and Parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
This drug may have the following side effects:
- itching,
- rash,
- fever,
- confusion,
- chest pain,
- blurred vision,
- fainting,
- agitation,
- unusual tiredness,
- sore throat,
- mood changes,
- drowsiness,
- severe stomach pain,
- depression,
- thoughts of suicide,
- swelling of the face, tongue or throat,
- severe dizziness, and
- trouble breathing
- hallucinations,
- eye pain,
- vomit that looks like coffee grounds,
- daytime sleepiness,
- easy bruising or bleeding,
- double vision,
- decreased vision,
- problems with urination,
- black or tarry stools,
- unusual strong urges (increased gambling, sexual urges),
- new or worsening movements you can’t control,
- greatly increased eye blinking or twitching,
- tingling of the hands and feet,
The following drugs are related to Rytary, either as a replacement or used together:
- Symmetrel (amantadine hydrochloride)
- Kynmobi (apomorphine hydrochloride sublingual film)
- Aricept (donepezil)
- Azilect (rasagiline)
- Parlodel (bromocriptine mesylate)
- Lodosyn (carbidopa)
- Dhivy (carbidopa and levodopa tablets)
- Stalevo (carbidopa, levodopa and entacapone)
- Sinemet (carbidopa-levodopa)
- Sinemet CR (carbidopa-levodopa sustained release)
- Eldepryl (selegiline hcl)
- Exelon (rivastigmine tartrate)
- Exelon Patch (rivastigmine transdermal system)
- Fluorodopa FDOPA (f18 injection)
- Inbrija (levodopa inhalation powder)
- Nourianz (istradefylline tablets)
- Mirapex (pramipexole)
- Mirapex ER (pramipexole dihydrochloride extended-release tablets)
- Ongentys (opicapone capsules)
- Permax (pergolide mesylate)
- Requip (ropinirole hcl)
- Requip XL (ropinirole extended release tablets)